Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

EGFR Signaling in Colorectal Carcinoma.

Krasinskas AM.

Patholog Res Int. 2011 Feb 14;2011:932932. doi: 10.4061/2011/932932.

2.

Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.

Uribe P, Gonzalez S.

Pathol Res Pract. 2011 Jun 15;207(6):337-42. doi: 10.1016/j.prp.2011.03.002. Epub 2011 Apr 29. Review.

PMID:
21531084
4.

Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer.

Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A.

J Natl Cancer Inst. 2009 Oct 7;101(19):1308-24. doi: 10.1093/jnci/djp280. Epub 2009 Sep 8. Review.

5.

Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer.

Kendall A, Lord R, Maisey N.

Recent Pat Anticancer Drug Discov. 2010 Jun;5(2):142-51. Review.

PMID:
19954416
6.

Predictive molecular markers of response to epidermal growth factor receptor(EGFR) family-targeted therapies.

Barton S, Starling N, Swanton C.

Curr Cancer Drug Targets. 2010 Dec;10(8):799-812. Review.

PMID:
20718710
8.

KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies.

Maus MK, Grimminger PP, Mack PC, Astrow SH, Stephens C, Zeger G, Hsiang J, Brabender J, Friedrich M, Alakus H, Hölscher AH, Lara P, Danenberg KD, Lenz HJ, Gandara DR.

Lung Cancer. 2014 Feb;83(2):163-7. doi: 10.1016/j.lungcan.2013.11.010. Epub 2013 Nov 21.

PMID:
24331409
9.

The epidermal growth factor receptor as a target for colorectal cancer therapy.

Lockhart AC, Berlin JD.

Semin Oncol. 2005 Feb;32(1):52-60. Review. Erratum in: Semin Oncol. 2005 Aug;32(4):432. Lockhart, Craig [corrected to Lockhart, A Craig].

PMID:
15726506
10.

Epidermal growth factor receptor: pathway, therapies, and pipeline.

Goffin JR, Zbuk K.

Clin Ther. 2013 Sep;35(9):1282-303. doi: 10.1016/j.clinthera.2013.08.007. Review.

PMID:
24054705
11.

Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.

Lu Y, Jingyan G, Baorong S, Peng J, Xu Y, Cai S.

Cancer Biomark. 2012;11(5):219-26. doi: 10.3233/CBM-2012-00282.

PMID:
23220854
12.

Molecular testing in colorectal cancer: diagnosis of Lynch syndrome and personalized cancer medicine.

Shi C, Washington K.

Am J Clin Pathol. 2012 Jun;137(6):847-59. doi: 10.1309/AJCPI83DINULUJNI.

PMID:
22586043
13.
14.

Epidermal growth factor receptor (EGFR) gene copy number in colorectal adenoma-carcinoma progression.

Flora M, Piana S, Bassano C, Bisagni A, De Marco L, Ciarrocchi A, Tagliavini E, Gardini G, Tamagnini I, Banzi C, Bisagni G.

Cancer Genet. 2012 Dec;205(12):630-5. doi: 10.1016/j.cancergen.2012.10.005. Epub 2012 Nov 20.

PMID:
23181982
15.

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

Benvenuti S, Sartore-Bianchi A, Di Nicolantonio F, Zanon C, Moroni M, Veronese S, Siena S, Bardelli A.

Cancer Res. 2007 Mar 15;67(6):2643-8.

16.

Assessment of Epidermal Growth Factor Receptor (EGFR) signaling in paired colorectal cancer and normal colon tissue samples using computer-aided immunohistochemical analysis.

Messersmith W, Oppenheimer D, Peralba J, Sebastiani V, Amador M, Jimeno A, Embuscado E, Hidalgo M, Iacobuzio-Donahue C.

Cancer Biol Ther. 2005 Dec;4(12):1381-6. Epub 2005 Dec 31.

PMID:
16319527
17.

EGFR as a potential target for the treatment of pancreatic cancer: dilemma and controversies.

Nedaeinia R, Avan A, Manian M, Salehi R, Ghayour-Mobarhan M.

Curr Drug Targets. 2014;15(14):1293-301. Review.

PMID:
25429712
18.

KRAS testing in metastatic colorectal cancer: implications on the use of biologic agents.

Bekaii-Saab T.

Clin Colorectal Cancer. 2009 Jul;8(3):135-40. doi: 10.3816/CCC.2009.n.022. Review.

PMID:
19632927
19.

Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives.

Spano JP, Fagard R, Soria JC, Rixe O, Khayat D, Milano G.

Ann Oncol. 2005 Feb;16(2):189-94. Review.

PMID:
15668269
20.

Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.

Spano JP, Milano G, Vignot S, Khayat D.

Crit Rev Oncol Hematol. 2008 Apr;66(1):21-30. doi: 10.1016/j.critrevonc.2007.11.005. Epub 2008 Feb 21. Review.

PMID:
18206383

Supplemental Content

Support Center